Clariane SE
Clariane SE (CLARI.PA) Stock Competitors & Peer Comparison
See (CLARI.PA) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CLARI.PA | €4.43 | -2.77% | 1.6B | -110.65 | -€0.04 | N/A |
| ORP.PA | €8.39 | +3.94% | 1.3B | 0.06 | €129.13 | N/A |
| GDS.PA | €10.45 | -0.48% | 1.2B | -14.51 | -€0.72 | N/A |
| KORI.PA | €7.36 | -3.79% | 778.6M | 29.44 | €0.25 | N/A |
| LNA.PA | €28.30 | -0.70% | 289.4M | 13.29 | €2.13 | +4.59% |
| PNSB.BR | €0.40 | N/A | 245K | N/A | N/A | N/A |
| MLSBT.PA | €5.30 | -2.75% | 0 | -17.10 | -€0.31 | N/A |
| ESP.AS | €0.01 | +0.00% | 0 | -0.01 | -€0.92 | N/A |
Stock Comparison
CLARI.PA vs ORP.PA Comparison August 2025
CLARI.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLARI.PA stands at 1.6B. In comparison, ORP.PA has a market cap of 1.3B. Regarding current trading prices, CLARI.PA is priced at €4.43, while ORP.PA trades at €8.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLARI.PA currently has a P/E ratio of -110.65, whereas ORP.PA's P/E ratio is 0.06. In terms of profitability, CLARI.PA's ROE is -0.00%, compared to ORP.PA's ROE of +0.77%. Regarding short-term risk, CLARI.PA is less volatile compared to ORP.PA. This indicates potentially lower risk in terms of short-term price fluctuations for CLARI.PA.Check ORP.PA's competition here